Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
US7816326B2 · kind B2 · utility
5Cited by
5References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 10, 2007 |
| Grant date | Oct 19, 2010 |
| Priority date | — |
| Expiry date | Oct 25, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/0804
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.